Despite past failures, Denali's extensive pipeline and solid financial runway make it a compelling buy at current low stock ...

Charles Schwab Investment Management Inc. grew its holdings in shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) ...